Surgery Partners, Inc. (NASDAQ:SGRY) Given Average Rating of "Moderate Buy" by Analysts

Shares of Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the eight ratings firms that are presently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $40.71.

Several equities research analysts have issued reports on the stock. Benchmark reiterated a "buy" rating and set a $50.00 price objective on shares of Surgery Partners in a research note on Monday, August 26th. UBS Group assumed coverage on Surgery Partners in a research report on Monday, October 14th. They issued a "buy" rating and a $38.00 target price for the company. Cantor Fitzgerald reiterated an "overweight" rating and set a $43.00 target price on shares of Surgery Partners in a report on Friday, October 4th. Macquarie restated an "outperform" rating and issued a $34.00 price target on shares of Surgery Partners in a report on Tuesday. Finally, Citigroup dropped their price objective on shares of Surgery Partners from $38.00 to $36.00 and set a "buy" rating on the stock in a research note on Wednesday, August 7th.

Surgery Partners Trading Up 4.2 %

Shares of NASDAQ SGRY traded up $0.92 during trading on Tuesday, hitting $22.75. 2,990,226 shares of the company traded hands, compared to its average volume of 967,019. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99. The firm has a market capitalization of $2.89 billion, a P/E ratio of -47.40, a P/E/G ratio of 16.86 and a beta of 2.76. The company has a 50-day moving average price of $30.45 and a 200-day moving average price of $28.46. Surgery Partners has a 1 year low of $21.36 and a 1 year high of $36.92.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last announced its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The firm had revenue of $770.40 million for the quarter, compared to analyst estimates of $768.99 million. During the same quarter in the prior year, the company earned $0.15 earnings per share. The business's revenue was up 14.3% compared to the same quarter last year. On average, equities analysts predict that Surgery Partners will post 0.83 EPS for the current year.

Institutional Trading of Surgery Partners

Hedge funds have recently bought and sold shares of the company. Quarry LP raised its position in shares of Surgery Partners by 133.1% during the 2nd quarter. Quarry LP now owns 3,082 shares of the company's stock worth $73,000 after buying an additional 1,760 shares in the last quarter. KBC Group NV lifted its position in Surgery Partners by 31.8% in the third quarter. KBC Group NV now owns 2,385 shares of the company's stock worth $77,000 after purchasing an additional 576 shares during the period. DekaBank Deutsche Girozentrale boosted its stake in Surgery Partners by 102.0% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company's stock valued at $80,000 after purchasing an additional 1,375 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. lifted its holdings in shares of Surgery Partners by 747.6% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,831 shares of the company's stock valued at $124,000 after buying an additional 3,379 shares during the period. Finally, EntryPoint Capital LLC boosted its stake in Surgery Partners by 257.1% during the first quarter. EntryPoint Capital LLC now owns 6,399 shares of the company's stock valued at $191,000 after buying an additional 4,607 shares in the last quarter.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.